Immunologic targeting of the tumor-specific antigen contained in the deletion mutation of the epidermal growth factor receptor (EGFRvIII) with peptide loaded dendritic cells in patients with malignant gliomas
Publication
, Conference
Archer, G; Bigner, D; Friedman, A; Friedman, H; Penne, K; Paolino, A; Smith, D; Reardon, D; Sampson, J
Published in: NEURO-ONCOLOGY
July 1, 2005
Duke Scholars
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
July 1, 2005
Volume
7
Issue
3
Start / End Page
350 / 350
Location
Edinburgh, SCOTLAND
Publisher
DUKE UNIV PRESS
Conference Name
2nd Quadrennial Meeting of the World-Federation-of-Neuro-Oncology/6th Meeting of the European-Association-for-Neur-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Archer, G., Bigner, D., Friedman, A., Friedman, H., Penne, K., Paolino, A., … Sampson, J. (2005). Immunologic targeting of the tumor-specific antigen contained in the deletion mutation of the epidermal growth factor receptor (EGFRvIII) with peptide loaded dendritic cells in patients with malignant gliomas. In NEURO-ONCOLOGY (Vol. 7, pp. 350–350). Edinburgh, SCOTLAND: DUKE UNIV PRESS.
Archer, G., D. Bigner, A. Friedman, H. Friedman, K. Penne, A. Paolino, D. Smith, D. Reardon, and J. Sampson. “Immunologic targeting of the tumor-specific antigen contained in the deletion mutation of the epidermal growth factor receptor (EGFRvIII) with peptide loaded dendritic cells in patients with malignant gliomas.” In NEURO-ONCOLOGY, 7:350–350. DUKE UNIV PRESS, 2005.
Archer G, Bigner D, Friedman A, Friedman H, Penne K, Paolino A, et al. Immunologic targeting of the tumor-specific antigen contained in the deletion mutation of the epidermal growth factor receptor (EGFRvIII) with peptide loaded dendritic cells in patients with malignant gliomas. In: NEURO-ONCOLOGY. DUKE UNIV PRESS; 2005. p. 350–350.
Archer, G., et al. “Immunologic targeting of the tumor-specific antigen contained in the deletion mutation of the epidermal growth factor receptor (EGFRvIII) with peptide loaded dendritic cells in patients with malignant gliomas.” NEURO-ONCOLOGY, vol. 7, no. 3, DUKE UNIV PRESS, 2005, pp. 350–350.
Archer G, Bigner D, Friedman A, Friedman H, Penne K, Paolino A, Smith D, Reardon D, Sampson J. Immunologic targeting of the tumor-specific antigen contained in the deletion mutation of the epidermal growth factor receptor (EGFRvIII) with peptide loaded dendritic cells in patients with malignant gliomas. NEURO-ONCOLOGY. DUKE UNIV PRESS; 2005. p. 350–350.
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
July 1, 2005
Volume
7
Issue
3
Start / End Page
350 / 350
Location
Edinburgh, SCOTLAND
Publisher
DUKE UNIV PRESS
Conference Name
2nd Quadrennial Meeting of the World-Federation-of-Neuro-Oncology/6th Meeting of the European-Association-for-Neur-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences